TY - JOUR
T1 - International Consortium on Mammographic Density
T2 - Methodology and population diversity captured across 22 countries
AU - International Consortium on Mammographic Density
AU - McCormack, Valerie A
AU - Burton, Anya
AU - dos-Santos-Silva, Isabel
AU - Hipwell, John H
AU - Dickens, Caroline
AU - Salem, Dorria
AU - Kamal, Rasha
AU - Hartman, Mikael
AU - Lee, Charmaine Pei Ling
AU - Chia, Kee-Seng
AU - Ozmen, Vahit
AU - Aribal, Mustafa Erkin
AU - Flugelman, Anath Arzee
AU - Lajous, Martín
AU - Lopez-Riduara, Ruy
AU - Rice, Megan
AU - Romieu, Isabelle
AU - Ursin, Giske
AU - Qureshi, Samera
AU - Ma, Huiyan
AU - Lee, Eunjung
AU - van Gils, Carla H
AU - Wanders, Johanna O P
AU - Vinayak, Sudhir
AU - Ndumia, Rose
AU - Allen, Steve
AU - Vinnicombe, Sarah
AU - Moss, Sue
AU - Won Lee, Jong
AU - Kim, Jisun
AU - Pereira, Ana
AU - Garmendia, Maria Luisa
AU - Sirous, Reza
AU - Sirous, Mehri
AU - Peplonska, Beata
AU - Bukowska, Agnieszka
AU - Tamimi, Rulla M
AU - Bertrand, Kimberly
AU - Nagata, Chisato
AU - Kwong, Ava
AU - Vachon, Celine
AU - Scott, Christopher
AU - Perez-Gomez, Beatriz
AU - Pollan, Marina
AU - Maskarinec, Gertraud
AU - Giles, Graham
AU - Hopper, John
AU - Stone, Jennifer
AU - Rajaram, Nadia
AU - Teo, Soo-Hwang
N1 - Copyright © 2015 Elsevier Ltd. All rights reserved.
PY - 2016/2
Y1 - 2016/2
N2 - Mammographic density (MD) is a quantitative trait, measurable in all women, and is among the strongest markers of breast cancer risk. The population-based epidemiology of MD has revealed genetic, lifestyle and societal/environmental determinants, but studies have largely been conducted in women with similar westernized lifestyles living in countries with high breast cancer incidence rates. To benefit from the heterogeneity in risk factors and their combinations worldwide, we created an International Consortium on Mammographic Density (ICMD) to pool individual-level epidemiological and MD data from general population studies worldwide. ICMD aims to characterize determinants of MD more precisely, and to evaluate whether they are consistent across populations worldwide. We included 11755 women, from 27 studies in 22 countries, on whom individual-level risk factor data were pooled and original mammographic images were re-read for ICMD to obtain standardized comparable MD data. In the present article, we present (i) the rationale for this consortium; (ii) characteristics of the studies and women included; and (iii) study methodology to obtain comparable MD data from original re-read films. We also highlight the risk factor heterogeneity captured by such an effort and, thus, the unique insight the pooled study promises to offer through wider exposure ranges, different confounding structures and enhanced power for sub-group analyses.
AB - Mammographic density (MD) is a quantitative trait, measurable in all women, and is among the strongest markers of breast cancer risk. The population-based epidemiology of MD has revealed genetic, lifestyle and societal/environmental determinants, but studies have largely been conducted in women with similar westernized lifestyles living in countries with high breast cancer incidence rates. To benefit from the heterogeneity in risk factors and their combinations worldwide, we created an International Consortium on Mammographic Density (ICMD) to pool individual-level epidemiological and MD data from general population studies worldwide. ICMD aims to characterize determinants of MD more precisely, and to evaluate whether they are consistent across populations worldwide. We included 11755 women, from 27 studies in 22 countries, on whom individual-level risk factor data were pooled and original mammographic images were re-read for ICMD to obtain standardized comparable MD data. In the present article, we present (i) the rationale for this consortium; (ii) characteristics of the studies and women included; and (iii) study methodology to obtain comparable MD data from original re-read films. We also highlight the risk factor heterogeneity captured by such an effort and, thus, the unique insight the pooled study promises to offer through wider exposure ranges, different confounding structures and enhanced power for sub-group analyses.
KW - Adult
KW - Aged
KW - Breast/abnormalities
KW - Breast Density
KW - Breast Neoplasms/epidemiology
KW - Female
KW - Humans
KW - Incidence
KW - International Agencies
KW - Mammary Glands, Human/abnormalities
KW - Mammography/methods
KW - Middle Aged
KW - Risk Factors
U2 - 10.1016/j.canep.2015.11.015
DO - 10.1016/j.canep.2015.11.015
M3 - Article (Academic Journal)
C2 - 26724463
SN - 1877-7821
VL - 40
SP - 141
EP - 151
JO - Cancer Epidemiology
JF - Cancer Epidemiology
ER -